middle.news
How Is OncoSil Medical Driving Record Growth and Expanding Across Europe?
9:51am on Thursday 30th of October, 2025 AEDT
•
Healthcare
Read Story
How Is OncoSil Medical Driving Record Growth and Expanding Across Europe?
9:51am on Thursday 30th of October, 2025 AEDT
Key Points
Record quarterly cash receipts of $0.64 million in Q1 FY26, up 917% year-over-year
Positive preliminary PANCOSIL Phase 1-2 study results demonstrating safety and efficacy
First OncoSil treatments performed in Portugal and Germany, marking European expansion
Appointment of Dr Thomas Duthy as Non-Executive Chairman to strengthen leadership
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
OSL
OPEN ARTICLE